| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 176,159 | 160,764 | 296,039 | 569,757 | | Cost of Revenue | 117,640 | 100,637 | 179,825 | 331,215 | | | Gross Profit | 58,519 | 60,127 | 116,214 | 238,542 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,571 | 18,236 | 19,984 | 18,478 | | Non Recurring | (350) | 176 | 174 | 19,075 | | Others | 70,131 | 68,857 | 70,347 | 71,034 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (27,285) | (27,142) | 25,709 | 129,955 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 829 | 216 | 84 | (161) | | Earnings Before Interest And Taxes | (27,004) | (26,926) | 25,793 | 129,794 | | Interest Expense | 1,448 | 839 | 447 | 174 | | Income Before Tax | (28,452) | (27,765) | 25,346 | 129,620 | | Income Tax Expense | (9,872) | (10,022) | 9,143 | 50,128 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,580) | (17,743) | 16,203 | 79,492 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,580) | (17,743) | 16,203 | 79,492 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,580) | ($17,743) | $16,203 | $79,492 |
|
1.39% Nasdaq 
Income Statement
